Author Description

Examines the Witnesses: Andrew Von Eschenbach, Dir., Nat. Cancer Institute (NCI); Donald A. Berry, M.D., Chmn., Dept. of Biostatistics, Anderson Cancer Center, Univ. of Texas, Houston, TX; Harmon J. Eyre, M.D., Chief Medical Officer & Exec. V.P. of Research & Medical Affairs, Amer. Cancer Soc., Wash., D.C.; Fran Visco, Pres., Nat. Breast Cancer Coalition, Wash., DC; Carolyn D. Runowicz, M.D. Vice Chmn., Dept. of Obstetrics & Gynecology, St. Luke's Roosevelt Hospital, N.Y., NY, On Behalf of the Amer. College of Obstetricians & Gynecologists; & LaSalle Leffall, Jr., M.D., Chmn.-Elect, Susan G. Komen Breast Cancer Fdn, Dallas, TX.